Study Overview
Sex: All
Age: 18 Years / N/A
No Study Documents
Study Overview
Sex: All
Age: 18 Years / N/A
No Study Documents
Completed
Tislelizumab in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma
Sex: All
Age: 18 Years / N/A
No Study Documents
Sex: All
Age: 18 Years / N/A
No Study Documents